Galit Frydman

Dr. Frydman holds positions in the Division of Trauma, Emergency Surgery and Surgical Critical Care at the Massachusetts General Hospital and in the Center for Biomedical Engineering at the Massachusetts Institute of Technology, where she specializes in coagulopathies and immunothrombosis. Dr. Frydman has completed several fellowships at MIT, HMS and MGH, where she developed Coagulo’s platform technology. She has published numerous papers and book chapters on coagulation, platelet physiology, immunothrombosis and stem cell biology. Dr. Frydman earned a ScD in Biological Engineering from MIT, a DVM from the University of Florida, and a BS in Biology from Carnegie Mellon University.